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Abstract 
Reaction of ethyl imidates derived from N-aryl-5-amino-4-cyanopyrazoles with amines or 
arylhydrazines gave only 4-substituted pyrazolo[3,4-d]pyrimidines, resulting from cyclization 
followed by Dimroth rearrangement. From the reaction with arylhydrazines, a mixture of the 
hydrazines and their oxidized forms, the azo products, was obtained. This was proven by an 
independent synthesis starting from the corresponding 4-chloropyrazolo[3,4-d]pyrimidines as 
starting material. The structures of the compounds obtained were confirmed by mass 
spectrometry, 1H and 13C NMR. 
 
Keywords: Cyanopyrazoles, pyrazolo[3,4-d]pyrimidines, Dimroth rearrangement  
 
 
 
Introduction 
 
In recent years, pyrazolopyrimidines and related fused heterocycles have been identified as 
bioactive molecules. They are known to function as CNS (Central Nervous System) depressants,1 
neuroleptic agents,2 and as tuberculostatic3. Pyrazolo[3,4-d]pyrimidines were identified as a 
general class of adenosine receptors.4,5 Moreover, fluorinated compounds find much importance 
in the pharmaceutical field.6 The introduction of a CF3 group provides compounds with increased 
lipophylicity and activity when compared to their non-fluorinated analogues. The trifluoromethyl 
substituted compounds have been reported to possess biological activity as herbicides, 
fungicides,7 analgesic, antipyretic, and inhibitors for platelet aggregation.8 
 We have concentrated our attention on ortho-aminocyanopyrazoles and their derivatives as 
inhibitors of xanthine oxidase.9 With the objective of synthesizing members of this class of 
compounds we started from the key intermediates 2a–d (ethyl N-4-cyano-1-(4-substituted)-1H-
pyrazol-5-ylformimidate). These compounds are readily prepared from the N1-substituted-5- 
amino-4-cyanopyrazoles 1 (Scheme 1) and react with arylhydrazine derivatives to produce 
pyrazolo[3,4-d]pyrimidines. The antifungal activity of these new heterocycles is currently being 
evaluated. 
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Results and Discussion 
 
The 5-amino-1-substitutedpyrazole-4-carbonitrile 1 were reacted with triethylorthoformate to 
give the corresponding ethoxymethylene amino derivatives 2 which are the key compounds for 
the preparation of pyrazolo[3,4-d]pyrimidine derivatives. Reaction of 2 with hydrazine hydrate 
was known to produce 4-imino-pyrazolo[3,4-d]pyrimidines10 3 with mp 236-238 ºC [Lit.10 mp 
235ºC]. When 2 was reacted with phenylhydrazine derivatives under reflux, rather than yielding 
4 as expected, two products were isolated as white and orange solids respectively. Based on 
spectroscopic data, as described below, to these compounds were assigned structures 5 and 6, 
respectively.  
 Several experiments were performed with different starting substituted pyrazoles, 1, varying 
the reaction time, Table 1.  A mixture of both compounds, 5 and 6, was obtained and their 
proportion depended on the reaction time,  longer heating time yielding mainly compounds 6 
(entries 1, 2 and 5 versus 6, 7 and 8). 
 The NMR spectrum of the white solid showed all the expected signals for two para-
substituted phenyl rings, two C-H singlets and two NH singlets, which could also agree with 
structure 4 in view of the previously reported results with hydrazine hydrate.10  
 No NH signals were found in the proton NMR of the orange solid. This absence suggested 
that the oxidized form of the hydrazine was present. We are therefore led to propose structures 5 
for the hydrazine form and 6 for the azo form; the rearrangement of 4 to 5 could be due to 
Dimroth rearrangement.11,12 Mass spectrometry confirmed the molecular weight of compounds 6. 
The structure of compound 4 was excluded based on NMR data. The one dimensional, 1H NMR 
of compound 5a showed all the expected signals for aromatic protons and two singlets at 10.04 
and 8.34 for the two NH protons, and this was not sufficient to differentiate between structures 
4a and 5a. For this reason, we obtained the HMQC and HMBC NMR spectra and made an 
unambiguous assignment in the 1H and 13C NMR spectrum (see experimental part). 
 In the HMBC spectrum, we observed an intense correlation peak between NH at 8.34 and 
carbon signals at 112.4 (C-2``, 6``), 145.6 (C-1``) and 161.0 ppm (C-4) which is characteristic 
only for structure 5a but not for 4a, because no correlation peak between the NH and C-6 was 
observed. 
 To confirm the structure of compounds 5 an independent route was followed reacting 4-
chloropyrazolopyrimidine 7, mp 139-140 ºC [Lit.14 mp 138-139 ºC], with p-tolylhydrazine, and 
the products isolated were the pyrazolo[3,4-d]pyrimidines 5a (25%) and 6a (54%) whose 
spectral characteristics were completely coincident with the samples obtained before (Scheme 2).  
 
General Papers                                                                                                               ARKIVOC 2007 (xvi) 92-100 
ISSN 1551-7012                                                       Page 94                                                       ©ARKAT USA, Inc. 
N
N
CN
N
X
OEt
HN
Y
NH2.HCl
EtOH
N
N
N
N
NH H
N
X
Y
N
N
N
N
NH
X
H
N Y
N
N
N
N
N
X
N Y
a, X = Cl, Y = CH3
b, X = Cl, Y = Br
c, X = Cl, Y = COOH
d, X = CH3, Y = CF3
e, X = CF3, Y = Cl
7-10h
2a-d
5a-e
6a,b,e
Zn/AcOH
1
N
N NH2
CN
X
a, X = H
b, X = Cl
c, X = CH3
d, X = CF3
Ac2O
CH(EtO)3
3
+
reflux 3h
N
N
N
N
NH
NH2
4
3 4
6
3a
7a
1´
1``
2`
2``
3`
3``
4`
4``N
H 2N
H 2
∆
(X 
= H
)
 
Scheme 1  
 
Table 1. Preparation of compounds 5 and 6 
Entry   Reaction time (hr) Yield (%) 
 X Y  Hydrazine 5 Azo 6 
1 Cl CH3 4 72 (5a) 20 (6a) 
2 Cl Br 4 68 (5b) 22 (6b) 
3 Cl COOH 4 55 (5c) * 
4 CH3 CF3 4 61 (5d) * 
5 CF3 Cl 4 70 (5e) 21 (6e) 
6 Cl CH3 7-10 10 (5a) 77 (6a) 
7 Cl Br 7-10 15 (5b) 56 (6b) 
8 CF3 Cl 7-10 18 (5e) 70 (6e) 
* The azo form was not isolated. 
 
 Moreover, compound 5a could be converted to compound 6a by long reflux in ethanolic 
triethylamine solution and compounds 6 were reduced by zinc in acetic acid to afford compounds 
5. These results also prove the correct structures of compounds 5 and 6 as suggested in scheme 1. 
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Scheme 2 
 
 It seemed of interest to study the analogous reactions of ethoxymethylene amino derivatives 
2 with amines. In this case, we considered that the presence of the amidine moiety may ensure 
the possibility of closure of the pyrimidine ring, resulting in novel derivatives of pyrazolo[3,4-
d]pyrimidine of significant interest for biological study, since such compounds are substituted 
analogues of the well-known drug allopurinol.13  
 As the amines for studying their reactions with the amidine 2b, we selected the relatively 
low-basicity m-anisidine and the more basic ammonia.  
 Heating ethoxymethylene amino derivatives 2b with amines led to the formation of 
pyrazolo[3,4-d]pyrimidines 9 and 10. The rates of these reactions differ quite significantly. In 
order for the process to go to completion (TLC), it was necessary to stir the reaction mixture for 
3 h in methanol at RT. A reaction time of 14 h in refluxing methanol was required for the least 
basic m-anisidine to react to completion. Again the reaction of 2b (X = Cl) with m-anisidine 
afforded the Dimroth rearrangement product 9 via the intermediate 8 (Scheme 3). The reaction of 
pyrazole 2b with ammonia led exclusively to the 4-aminopyrazolo[3,4-d]pyrimidine derivative 
10 with mp 280-282 ºC [Lit. 14 mp 284 ºC]. 
 The alternative structure 8 was excluded based on NMR data. The one-dimensional 1H NMR 
spectrum, showed all the expected signals with protons 3 and 6 overlapping in a sharp singlet at 
8.54 ppm (integrating for two protons) and a sharp NH signal at 10.19 ppm. 
In the HMBC spectrum, we observe an intense correlation peak for the NH proton with the peaks 
at 107.2 (C-2``) and 113.5 ppm (C-6``) which is characteristic only of structure 9 but not for 8, 
where the indicated proton and carbon atoms are separated by five bonds. 
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 The structure of compounds 9 could also be confirmed by reaction of 4-
chloropyrazolopyrimidine 7 with m-anisidine (Scheme 3). 
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Scheme 3 
 
 In conclusion reaction of various monosubstituted hydrazines with ethyl N-4-cyano-1-(4-
substituted)-1H-pyrazol-5-ylformimidate 2 yields a mixture of the Dimroth rearrangement 
products, 5, together with their oxidized forms 6. The proportion of 5 and 6 depends on the 
reaction time; longer heating yielding mainly compounds 6. Reduction of compounds 6 afforded 
the corresponding hydrazinyl derivatives 5. Reaction of compound 2 with m-anisidine afforded 
only the Dimroth rearrangement product 9. 
 
 
Experimental Section 
 
General Procedures. Melting points were determined on a Gallenkamp melting point apparatus 
and are uncorrected. IR spectra were registered on a Perkin Elmer FTIR-1600. 1H NMR (300 
MHz) and 
13
C NMR (75.4 MHz) spectra were recorded on a Varian Unity Plus Spectrometer. 
Double resonance, HMQC and HMBC experiments were carried out for complete assignment of 
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proton and carbon signals in the NMR spectra, whenever possible. High resolution mass spectra 
were obtained on a AutoSpec E spectrometer. Elemental analyses were obtained on a Leco 
CHNS-932 instrument. Compounds 3, 7 and 10 were prepared by known methods.10,14 
 
General procedure for preparation of 2a-e 
A mixture of 5-amino-4-cyano-1-substituted pyrazole (0.2 mol), triethylorthoformate (20 ml) and 
acetic anhydride (20 ml) was heated under reflux for 7 h and then evaporated under reduced 
pressure. The residue was treated with ethanol and the solid product so formed was collected by 
filtration, washed with ethanol and crystallized from EtOH-H2O. 
Ethyl N-(4-cyano-1-phenyl-1H-pyrazol-5-yl)formimidate (2a). Yield (82%), white solid, mp 
56-57 oC (EtOH-H2O); 1H NMR (DMSO-d6) δ = 1.37 (t, 3H, J = 7.5Hz, CH3), 4.45 (q, 2H, J = 
7.5Hz, CH2), 7.47-7.63 (m, 5H, Ar-H), 7.83 (s, 1H, pyrazole-H), 8.39 (s, 1H, HC=N). Anal. 
Calcd: C, 64.99; H, 5.03; N, 23.32; Found: C, 64.85; H, 5.09; N, 23.57. 
Ethyl N-[1-(4-chlorophenyl)-4-cyano-1H-pyrazol-5-yl]formimidate (2b). Yield (78%), white 
solid, mp 69-70 oC (EtOH-H2O); 1H NMR (CDCl3) δ = 1.37 (t, 3H, J = 7.5Hz, CH3), 4.34 (q, 
2H, J = 7.5 Hz, CH2), 7.47 (d, 2H, J = 9Hz, Ar-H), 8.14 (d, 2H, J = 9Hz, Ar-H), 8.20 (s, 1H, 
pyrazole-H), 8.42 (s, 1H, HC=N). Anal. Cald for C13H11ClN4O: C, 56.84; H, 4.04; N, 20.40. 
Found: C, 56.58; H, 4.03; N, 20.10. 
Ethyl N-[4-cyano-1-(p-tolyl)-1H-pyrazol-5-yl]formimidate (2c). Yield (75%), white solid, mp 
82-84 oC (EtOH-H2O); 1H NMR (CDCl3) δ = 1.37 (t, 3H, J = 7.5Hz, CH3), 2.40 (s, 3H, CH3), 
4.34 (q, 2H, J = 7.5 Hz, CH2), 7.24 (d, 2H, J = 9Hz, Ar-H), 7.50 (d, 2H, J = 9Hz, Ar-H), 7.80 (s, 
1H, pyrazole-H), 8.38 (s, 1H, HC=N). MS (EI) m/z 254 (M+, 100), 226(12), 225(20), 209(23), 
198(76), 197(20), 91(10). Anal. Cald for C14H14N4O: C, 66.13; H, 5.55; N, 22.03. Found: C, 
66.29; H, 5.50; N, 22.09. 
Ethyl N-{4-cyano-1-[4-(trifluoromethyl)phenyl]-1H-pyrazol-5-yl}formimidate (2d). Yield 
(74%), yellowish white solid, mp 92-94 oC (EtOH-H2O); IR = 2227 (CN), 1630 (C=N); 1H NMR 
(CDCl3) δ = 1.30 (t, 3H, J = 7.5Hz, CH3), 4.32 (q, 2H, J = 7.5 Hz, CH2), 7.88-7.95 (m, 4H, Ar-
H), 8.24 (s, 1H, pyrazole-H), 8.57 (s, 1H, HC=N). Anal. Cald for C14H11F3N4O: C, 54.55; H, 
3.60; N, 18.18. Found: C, 54.61; H, 3.67; N, 18.07. 
 
Reaction with phenylhydrazine derivatives 
Method A. Reaction of ethyl N-4-cyano-1-(4-substitutedphenyl)-1H-pyrazol-5-yl 
formimidate 
To a solution of pyrazol-5-ylformimidate (0.1 mol) in ethanol (20 ml), phenylhydrazine 
derivative (0.1 mol) was added (a catalytic amount of triethylamine was added in the case of 
phenylhydrazine HCl). The reaction mixture was heated under reflux for 7-10 h. The orange 
precipitate formed after cooling was filtered off, dried and recrystallized from ethanol to afford 
the oxidized product as an orange solid (except for entries 3 and 4, table 1, where no orange solid 
precipitated on cooling). The mother liquor was poured onto ice and the solid formed was 
filtered off and crystallized from EtOH to produce the hydrazinyl product as a white powder.  
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Method B. Reaction of 1-(4-chlorophenyl)-4-chloropyrazolo[3,4-d]pyrimidine with phenyl 
hydrazine derivatives 
To a solution of 4-chloropyrazolo[3,4-d]pyrimidine (0.1 mol) in ethanol (20 ml) was added the 
phenylhydrazine derivative (0.1 mol) and a catalytic amount of triethylamine. The reaction 
mixture was heated under reflux for 7 h. It was followed the same work up as mentioned above. 
1-(4-Chlorophenyl)-4-(2-p-tolylhydrazinyl)-1H-pyrazolo[3,4-d]pyrimidine (5a). Yield (72%), 
white solid, mp 234-235 oC (EtOH); 1H NMR (DMSO-d6) δ = 2.17(s, 3H, CH3), 6.70 (d, 2H, J = 
9Hz, H-2” and 6”), 7.01 (d, 2H, J = 9Hz, H-3” and 5”), 7.60 (d, 2H, J = 9Hz, H-3’ and 5’), 8.09 
(s, 1H, H-3), 8.20 (d, 2H, J = 9Hz, H-2’ and 6’), 8.34 (s, 1H, NH), 8.40 (s, 1H, H-6), 10.04 (s, 
1H, NH); 13C NMR (DMSO-d6) δ = 20.2 (CH3), 99.7 (C-3a), 112.4 (C-2``), 122.1 (C-2`), 128.2  
(C-4``), 129.2 (C-3`), 129.7 (C-3``), 130.2 (C-4`), 136.0 (C-3), 137.6 (C-1`), 145.6 (C-1``), 154.0 
(C-7a), 156.2 (C-6), 161.0 (C-4). MS (EI) = 352 (M +, 37Cl, 2.8%), 350 (M+, 35Cl, 7%), 247(18), 
245(100), 107(30), 106(52). Anal. Calcd for C18H15ClN6: C, 61.63; H, 4.31; N, 23.96. Found: C, 
61.41; H, 4.19; N, 23.96. 
4-[2-(4-Bromophenyl)hydrazinyl]-1-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidine (5b). 
Yield (68%), white solid, mp 191-192 oC (EtOH); 1H NMR (CDCl3) δ = 6.19 (s, 1H, NH), 6.84 
(d, 2H, J = 9Hz, Ar-H), 7.40 (d, 2H, J = 9Hz, Ar-H), 7.47 (d, 2H, J = 9Hz, Ar-H), 7.67 (brs, 1H, 
NH), 8.16 (d, 2H, J = 9Hz, Ar-H), 8.23 (s, 1H, H-3), 8.40 (s, 1H, H-6). Anal. Calcd for 
C17H12BrClN6: C, 49.12; H, 2.91; N, 20.22. Found : C, 49.40; H, 3.10; N, 19.91. 
4-{2-[1-(4-Chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]hydrazinyl}benzoic acid (5c). 
Yield (55%), white solid, mp 284-286 oC (EtOH-DMF); 1H NMR (DMSO-d6) δ = 6.85 (d, 2H, J 
= 9Hz, Ar-H), 7.59 (d, 2H, J = 9Hz, Ar-H), 7.80 (d, 2H, J = 9Hz, Ar-H), 8.04 (s, 1H, H-3), 8.21 
(d, 2H, J = 9Hz, Ar-H), 8.44 (s, 1H, H-6), 9.12 (s, 1H, NH), 10.26 (brs, 1H, NH), 12.18 (brs, 1H, 
COOH). MS (FB+)= 382 ((M +,37Cl, 8%), 380(M+,35Cl, 17%). Anal. Cald for C18H13ClN6O2 ½ 
H2O: C, 55.53; H, 3.59; N, 21.59. Found: C, 55.71; H, 3.88; N 21.54. 
1-p-Tolyl-4-{2-[4-(trifluoromethyl)phenyl]hydrazinyl}-1H-pyrazolo[3,4-d]pyrimidine (5d). 
Yield (61%), white solid, mp 224-225 oC (EtOH); 1H NMR (CDCl3) δ = 2.40 (s, 3H, CH3), 6.52 
(s, 1H, NH), 6.99 (d, 2H, J = 9Hz, Ar-H), 7.31 (d, 2H, J = 9Hz, Ar-H), 7.54 (d, 2H, J = 9Hz, Ar-
H), 7.97 (d, 2H, J = 9Hz, Ar-H), 8.09 (brs, 1H, NH), 8.14 (s, 1H, H-3), 8.42 (s, 1H, H-6). 
MS(FB+) = 386((M+2)+, 22%), 385 ((M+1)+, 100%), 384 (M+, 54%). Anal. Calcd for 
C19H15F3N6: C, 59.37; H, 3.93; N, 21.87. Found: C, 59.31; H, 4.00; N, 21.68. 
4-[2-(4-Chlorophenylhydrazinyl)]-1-[4-(trifluoromethyl)phenyl]-1H-pyrazolo[3,4-
d]pyrimidine (5e). Yield (70%), white solid, mp 199-200 oC (EtOH); 1H NMR (CDCl3) δ = 6.20 
(s, 1H, NH), 6.89 (d, 2H, J = 9Hz, Ar-H), 7.25 (d, 2H, J = 9Hz, Ar-H), 7.75 (brs, 1H, NH), 7.77 
(d, 2H, J = 9Hz, Ar-H), 8.26 (s, 1H, H-3), 8.42 (d, 2H, J = 9Hz, Ar-H), 8.46 (s, 1H, H-6). Anal. 
Calcd for C18H12ClF3N6: C, 53.41; H, 2.99; N, 20.76. Found: C, 53.86; H, 3.18; N, 20.46. 
1-(4-Chlorophenyl)-4-(p-tolyldiazenyl)-1H-pyrazolo[3,4-d]pyrimidine (6a). Yield (77%), 
orange solid, mp 204-205 oC (EtOH); 1H NMR (CDCl3) δ = 2.52 (s, 3H, CH3), 7.44 (d, 2H, J = 
9Hz, Ar-H), 7.55 (d, 2H, J = 9Hz, Ar-H), 8.12 (d, 2H, J = 9Hz, Ar-H), 8.29 (d, 2H, J = 9Hz, Ar-
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H), 8.66 (s, 1H, H-3), 9.28 (s, 1H, H-6). Anal. Calcd for C18H13ClN6: C, 61.98; H, 3.76; Cl, 
10.16; N, 24.09. Found: C, 61.90; H, 4.02; N, 23.72. 
4-[(4-Bromophenyl)diazenyl]-1-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidine (6b). Yield 
(56%), orange solid, mp 330-332 oC (EtOH); 1H NMR (CDCl3) δ = 7.57 (d, 2H, J = 9Hz, Ar-H), 
7.80 (d, 2H, J = 9Hz, Ar-H), 8.09 (d, 2H, J = 9Hz, Ar-H), 8.29 (d, 2H, J = 9Hz, Ar-H), 8.63 (s, 
1H, H-3), 9.30 (s, 1H, H-6). Anal. Calcd for C17H10BrClN6: C, 49.36; H, 2.44; N, 20.32. Found: 
C, 49.29; H, 2.59; N 19.94. 
4-[(4-Chlorophenyl)diazenyl]-1-[4-(trifluoromethyl)phenyl]-1H-pyrazolo[3,4-d]pyrimidine 
(6e). Yield (70%), orange solid, mp 204-205 oC (EtOH); 1H NMR (CDCl3) δ = 7.64 (d, 2H, J = 
9Hz, H-2” and 6”), 7.86 (d, 2H, J = 8.7 Hz, H-3’ and 5’), 8.17 (d, 2H, J = 8.4 Hz, H-3” and 5”), 
8.56 (d, 2H, J = 8.7 Hz, H-2´and 6’), 8.67 (s, 1H, H-3), 9.33 (s, 1H, H-6); 13C NMR (CDCl3) δ =  
105.4 (C-3a), 121.1 (C-2` and C-6’), 122.09 and 125.70 (right hand side of q, 1J= 272 Hz, CF3), 
125.5 (C-3`` and C-5”), 128.75 (q, 2J= 24,5 Hz, C-4’) 126.4 (q, 3J= 4Hz, C-3’ and C-5’), 130.0 
(C-2`` and C-6”), 135.6 (C-3), 140.8 (C-1” or C-4”), 141.2 (C-1’), 150.9 (C-1” or C-4”), 155.8 
(C-7a), 156.4 (C-6), 161.9 (C-4). MS(FB+) = 405 ((M +, 37Cl, 16,7%), 403(M+, 35Cl, 35.5%). 
Anal. Calcd for C18H10ClF3N6: C, 53.68; H, 2.50; N, 20.87. Found: C, 53.50; H, 2.66; N 20.60. 
 
Reduction of diazenyl derivatives to hydrazinyl derivatives, with Zn/AcOH (conversion of 
compounds 6 to 5) 
To a solution of diazenyl derivatives 6 (0.1 mol) in glacial acetic acid (25 ml), Zn dust (2 g) was 
added. The reaction mixture was refluxed for 2 h during which time the color turned to pale 
yellow. The reaction mixture was filtered while hot, left to cool to RT and then poured onto 
crushed ice (25 g). The precipitated solid was collected by filtration and recrystalized from 
CHCl3 to afford the corresponding hydrazinyl derivative which was found identical in all 
respects with that obtained from the above reaction (TLC, mp, NMR). (5a, 74 % yield, 5b, 58 
%yield, 5e, 65 % yield). 
 
Reactions with m-anisidine 
Method A. To a solution of pyrazol-5-ylformimidate (0.1 mol) in methanol (20 ml) was added 
m-anisidine (0.1 mol). The reaction mixture was heated under reflux for 14 h. The precipitate 
formed after cooling overnight was filtered off and dried and recrystallized from ethanol (77% 
yield). 
Method B. To a solution of 4-chloropyrazolo[3,4-d]pyrimidine (0.1 mol) in methanol (20 ml)  
was added m-anisidine (0.1 mol). The reaction mixture was refluxed for 5 h. The precipitate 
formed during reflux was filtered off and found identical in all respect with that obtained from 
method A (85 %). 
1-(4-Chlorophenyl)-N-(3-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine (9). Yield 
(77%), pale yellow solid, mp 215-217 oC (EtOH); 1H NMR (DMSO-d6) δ = 3.77 (s, 3H, OCH3), 
6.72 (dd, 1H, J = 8.4, 2.7 Hz, Ar-H), 7.29 (t, 1H, J = 8 Hz, Ar-H), 7.42 (d, 1H, J = 8 Hz, Ar-H), 
7.54 (t, 1H, J = 2.1 Hz, Ar-H), 7.61 (d, 2H, J = 9Hz, Ar-H), 8.24 (d, 2H, J = 9Hz, Ar-H), 8.54 (s, 
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2H, H-3, H-6), 10.19 (s, 1H, NH); 13C NMR (DMSO) δ =55.1 (OCH3), 102,6 (C-3a), 107.2 (C-
2``), 109.0 (C-4``), 113.5 (C-6``), 122.0 (C-2`), 129.2 (C-3`), 129.5 (C-5``), 130.3 (C-4`), 134.1 
(C-3), 137.6 (C-1`), 140.0 (C-1``), 153.1 (C-7a), 154.5 (C-4), 156.2 (C-6), 159.5 (C-3``). MS 
(EI)= 353 ((M+, 37Cl, 7%), 352 (M+-1,  37Cl, 22%), 351 (M+, 35Cl, 35%), 350 (M+-1, 35Cl, 100%). 
Anal. Calcd for C18H14ClN5O: C, 61.46; H, 4.01; N, 19.91. Found: C, 61.15; H, 4.35; N 19.78. 
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